BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20350124)

  • 1. Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
    Huang RS; Dolan ME
    Pharmacogenomics; 2010 Apr; 11(4):471-4. PubMed ID: 20350124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy number polymorphisms and anticancer pharmacogenomics.
    Gamazon ER; Huang RS; Dolan ME; Cox NJ
    Genome Biol; 2011; 12(5):R46. PubMed ID: 21609475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and pharmacogenomics of anticancer agents.
    Huang RS; Ratain MJ
    CA Cancer J Clin; 2009; 59(1):42-55. PubMed ID: 19147868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomic discovery approaches: will the real genes please stand up?
    Walgren RA; Meucci MA; McLeod HL
    J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using pharmacogene polymorphism panels to detect germline pharmacodynamic markers in oncology.
    Hertz DL; McLeod HL
    Clin Cancer Res; 2014 May; 20(10):2530-40. PubMed ID: 24831276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.
    Sauna ZE; Kimchi-Sarfaty C; Ambudkar SV; Gottesman MM
    Cancer Res; 2007 Oct; 67(20):9609-12. PubMed ID: 17942888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of Chemotherapy-Induced Cardiotoxicity.
    Chang VY; Wang JJ
    Curr Oncol Rep; 2018 Apr; 20(7):52. PubMed ID: 29713898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and challenges in hereditary cancer pharmacogenetics.
    Cascorbi I; Werk AN
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):73-82. PubMed ID: 27603572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.
    Guchelaar HJ; Gelderblom H; van der Straaten T; Schellens JH; Swen JJ
    Clin Pharmacol Ther; 2014 Apr; 95(4):383-5. PubMed ID: 24448475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future prospects for pharmacogenetics in the quest for personalized medicine.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):13-6. PubMed ID: 23457712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of sex difference in chemotherapeutic toxicity.
    Wang J; Huang Y
    Curr Drug Discov Technol; 2007 Jun; 4(1):59-68. PubMed ID: 17630929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical translation of cell-based pharmacogenomic discovery.
    Cox NJ; Gamazon ER; Wheeler HE; Dolan ME
    Clin Pharmacol Ther; 2012 Oct; 92(4):425-7. PubMed ID: 22910437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics and cancer stem cells: a changing landscape?
    Crea F; Duhagon MA; Farrar WL; Danesi R
    Trends Pharmacol Sci; 2011 Aug; 32(8):487-94. PubMed ID: 21529973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the development and use of pharmacogenomic markers in oncology.
    Innocenti F
    J Support Oncol; 2007 Jan; 5(1):15-6. PubMed ID: 17265781
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of single-nucleotide polymorphism maps in pharmacogenomics.
    McCarthy JJ; Hilfiker R
    Nat Biotechnol; 2000 May; 18(5):505-8. PubMed ID: 10802616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer pharmacogenomics: strategies and challenges.
    Wheeler HE; Maitland ML; Dolan ME; Cox NJ; Ratain MJ
    Nat Rev Genet; 2013 Jan; 14(1):23-34. PubMed ID: 23183705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in pharmacogenomic research and development.
    McCarthy JJ
    Mol Biotechnol; 2003 Nov; 25(3):275-82. PubMed ID: 14668540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.